Javascript must be enabled to continue!
Regulation of Hippo signaling by Atrophin in the developing Drosophila wing
View through CrossRef
ABSTRACT
Organ development is directed through integration of signaling networks and their transcriptional programs. We have investigated connections between Hippo signaling and the transcriptional co-repressor Atrophin. We find that Atrophin modulates Hippo signaling outputs in the developing
Drosophila
wing and does so in distinct ways in different regions. Near the dorsal-ventral boundary, loss of Atrophin leads to upregulation of targets of the Hippo pathway transcription factor Yorkie. This is explained by impairment of Notch signaling, and consequent downregulation of Vestigial, which normally competes with Yorkie for binding to Scalloped. In proximal regions of the wing disc, loss of Atrophin leads to downregulation of Yorkie activity. This is explained by downregulation of Dachs, as Dachs inhibits Warts, the central kinase controlling Yorkie activity. Downregulation of Dachs is explained by modulation of its upstream regulators Dachsous and Four-jointed, which is explained in turn by our discovery that Atrophin interacts genetically and physically with Vestigial and competes with Scalloped for Vestigial binding. These studies define new roles for Atrophin and enhance our understanding of the interplay of transcriptional activators and repressors that modulate Hippo signaling to shape wing development.
Title: Regulation of Hippo signaling by Atrophin in the developing
Drosophila
wing
Description:
ABSTRACT
Organ development is directed through integration of signaling networks and their transcriptional programs.
We have investigated connections between Hippo signaling and the transcriptional co-repressor Atrophin.
We find that Atrophin modulates Hippo signaling outputs in the developing
Drosophila
wing and does so in distinct ways in different regions.
Near the dorsal-ventral boundary, loss of Atrophin leads to upregulation of targets of the Hippo pathway transcription factor Yorkie.
This is explained by impairment of Notch signaling, and consequent downregulation of Vestigial, which normally competes with Yorkie for binding to Scalloped.
In proximal regions of the wing disc, loss of Atrophin leads to downregulation of Yorkie activity.
This is explained by downregulation of Dachs, as Dachs inhibits Warts, the central kinase controlling Yorkie activity.
Downregulation of Dachs is explained by modulation of its upstream regulators Dachsous and Four-jointed, which is explained in turn by our discovery that Atrophin interacts genetically and physically with Vestigial and competes with Scalloped for Vestigial binding.
These studies define new roles for Atrophin and enhance our understanding of the interplay of transcriptional activators and repressors that modulate Hippo signaling to shape wing development.
Related Results
The tumor-suppressor and cell adhesion molecule Fat controls planar polarity via physical interactions with Atrophin, a transcriptional co-repressor
The tumor-suppressor and cell adhesion molecule Fat controls planar polarity via physical interactions with Atrophin, a transcriptional co-repressor
Fat is an atypical cadherin that controls both cell growth and planar polarity. Atrophin is a nuclear co-repressor that is also essential for planar polarity; however, it is not kn...
On Hippo of (Possibly) Rhegium
On Hippo of (Possibly) Rhegium
The Presocratic philosopher and medical writer Hippo is best known for two allusions, both markedly negative, in Aristotle (De Anima 405b1-5, Metaphysics 984a3-5). In the Metaphysi...
Data from Oxytocin Receptor Regulates the Hippo/YAP Axis to Drive Hepatocarcinogenesis
Data from Oxytocin Receptor Regulates the Hippo/YAP Axis to Drive Hepatocarcinogenesis
<div>Abstract<p>Dysregulation of Hippo signaling, especially the downstream effector YAP, is a critical driver of hepatocellular carcinoma (HCC). Therefore, identifying...
Data from Targeting Hippo-Dependent and Hippo-Independent YAP1 Signaling for the Treatment of Childhood Rhabdomyosarcoma
Data from Targeting Hippo-Dependent and Hippo-Independent YAP1 Signaling for the Treatment of Childhood Rhabdomyosarcoma
<div>Abstract<p>Rhabdomyosarcoma is the most common childhood soft-tissue sarcoma, yet patients with metastatic or recurrent disease continue to do poorly, indicating a...
Prognostic Stratification of Epithelioid Pleural Mesothelioma Based on the Hippo-TEADs Network
Prognostic Stratification of Epithelioid Pleural Mesothelioma Based on the Hippo-TEADs Network
Background. The Hippo pathway is the most frequently altered signaling in pleural mesothelioma (PM). Epithelioid PM (ePM) is associated with better outcome than non-epithelioid sub...
Exploring the Targets of Gulao Yukang Pill in Rheumatoid Arthritis via the Hippo Signaling Pathway: An Integrated Network Pharmacology and Experimental Validation Study
Exploring the Targets of Gulao Yukang Pill in Rheumatoid Arthritis via the Hippo Signaling Pathway: An Integrated Network Pharmacology and Experimental Validation Study
ABSTRACTObjectiveInvestigating the Mechanism of Gulao Yukang Pill (GLYK) in Treating Rheumatoid Arthritis (RA) via the Hippo signaling pathway and Its Regulatory Effects on Th17/Tr...
KSR1 is a scaffold for the Hippo signaling pathway
KSR1 is a scaffold for the Hippo signaling pathway
Abstract
The evolutionarily conserved Hippo signaling pathway regulates organ size and tissue homeostasis. Yes-associated protein (YAP) functions as a transcripti...
Actin cytoskeletal deregulation, caused by RhoGEF2 overexpression, induces cell competition dependent on Ptp10D, Crumbs, and the Hippo signaling pathway
Actin cytoskeletal deregulation, caused by RhoGEF2 overexpression, induces cell competition dependent on Ptp10D, Crumbs, and the Hippo signaling pathway
Abstract
In
Drosophila
larval epithelial tissues, cells containing mutations in the apico-basal polarity prot...

